Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Journal of the ASEAN Federation of Endocrine Societies ; : 22-28, 2019.
Article in English | WPRIM | ID: wpr-960976

ABSTRACT

@#<p><strong>OBJECTIVES:</strong> Diagnosis of Turner syndrome in Malaysia is often late. This may be due to a lack of awareness of the wide clinical variability in this condition. In our study, we aim to examine the clinical features of all our Turner patients during the study period and at presentation.</p><p><strong>METHODOLOGY:</strong> This was a cross-sectional study. Thirty-four (34) Turner patients were examined for Turner-specific clinical features. The karyotype, clinical features at presentation, age at diagnosis and physiologic features were retrieved from their medical records.</p><p><strong>RESULTS:</strong> Patients with 45,X presented at a median age of 1 month old with predominantly lymphoedema and webbed neck. Patients with chromosome mosaicism or structural X abnormalities presented at a median age of 11 years old with a broader clinical spectrum, short stature being the most common presenting clinical feature. Cubitus valgus deformity, nail dysplasia and short 4th/5th metacarpals or metatarsals were common clinical features occurring in 85.3%-94.1% of all Turner patients. Almost all patients aged ?2 years were short irrespective of karyotype.</p><p><strong>CONCLUSION:</strong> Although short stature is a universal finding in Turner patients, it is usually unrecognised till late. Unlike the 45,X karyotype, non-classic Turner syndrome has clinical features which may be subtle and difficult to discern. Our findings underscore the importance of proper serial anthropometric measurements in children. Awareness for the wide spectrum of presenting features and careful examination for Turner specific clinical features is crucial in all short girls to prevent a delay in diagnosis.</p>


Subject(s)
Humans , Turner Syndrome , Karyotype
2.
The Medical Journal of Malaysia ; : 92-93, 2019.
Article in English | WPRIM | ID: wpr-821418

ABSTRACT

@#Testicular adrenal rest tumours (TART) are aberrant adrenal tissue within the testes (1). Although benign, they can lead to obstruction of the seminiferous tubules and infertility in patients with congenital adrenal hyperplasia (CAH). We report six boys who developed TART, a complication of CAH. Diagnosis was confirmed by ultrasound and testicular vein sampling of elevated 17-hydroxyprogesterone (17-OHP) levels. Glucocorticoids dosages were increased 1½-2 folds to suppress size of the aberrant adrenal tissues. Despite reductions in 17-OHP, the lesions remained unchanged. Three patients had testis-sparing surgery to excise the TART and to preserve normal testicular tissues.

3.
Singapore medical journal ; : e142-4, 2012.
Article in English | WPRIM | ID: wpr-249698

ABSTRACT

Neonatal diabetes mellitus (DM) is defined as insulin-requiring DM in the first six months of life. Unlike type 1 DM, it is a monogenic disorder resulting from a de novo mutation in the genes involved in the development of the pancreas, β-cell mass or secretory function. The majority of neonatal DM cases are caused by a heterozygous activating mutation in the KCNJ11 or ABCC8 genes that encode the Kir6.2 and SUR1 protein subunits, respectively, in the KATP channel. Sulphonylurea, a KATP channel inhibitor, can restore insulin secretion, hence offering an attractive alternative to insulin therapy. We report three cases of neonatal DM and their genetic mutations. Two patients were successfully switched over to sulphonylurea monotherapy with resultant improvement in the quality of life and a more stable blood glucose profile. Patients with neonatal DM should undergo genetic evaluation. For patients with KCNJ11 and ABCC8 gene mutation, oral sulphonylurea should be considered.


Subject(s)
Female , Humans , Infant , Infant, Newborn , Male , ATP-Binding Cassette Transporters , Genetics , Blood Glucose , Metabolism , Diabetes Mellitus , Genetics , Therapeutics , Genotype , Heterozygote , Models, Biological , Models, Genetic , Molecular Biology , Mutation , Pancreas , Physiology , Potassium Channels, Inwardly Rectifying , Genetics , Quality of Life , Receptors, Drug , Genetics , Sulfonylurea Compounds , Therapeutic Uses , Sulfonylurea Receptors
SELECTION OF CITATIONS
SEARCH DETAIL